mitiglinide has been researched along with Diabetic Angiopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, Y; Imai, J; Izumi, T; Kaneko, K; Katagiri, H; Satake, C; Sawada, S; Tanaka, M; Yamada, T; Yamamoto, J | 1 |
| Hashikata, T; Hatakeyama, Y; Kameda, R; Kitasato, L; Tojo, T; Yamaoka-Tojo, M | 1 |
| Arakawa, M; Hirose, T | 1 |
2 review(s) available for mitiglinide and Diabetic Angiopathies
| Article | Year |
|---|---|
Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Humans; Hypoglycemic Agents; Isoindoles; Postprandial Period; Treatment Outcome | 2012 |
[Glinide(s), sulfonylurea(s)].
Topics: Arteriosclerosis; Cardiovascular Diseases; Cyclohexanes; Diabetic Angiopathies; Glucose Intolerance; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Isoindoles; Nateglinide; Phenylalanine; Postprandial Period; Risk Factors; Sulfonylurea Compounds | 2006 |
1 other study(ies) available for mitiglinide and Diabetic Angiopathies
| Article | Year |
|---|---|
Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Inositol; Insulin; Insulin Antibodies; Insulin Secretion; Isoindoles; Liraglutide; Male; Postprandial Period; Treatment Outcome | 2019 |